Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models (Q46813413)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yumiko Tomono

1

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Masaru Iwai

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Shinji Inaba

3

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Masaki Mogi

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Masatsugu Horiuchi

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

publication date

10 January 2008

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Journal of Clinical Hypertension

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

21

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

206-212

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Angiotensin blockade prevents type 2 diabetes by formation of fat cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Angiotensin II-mediated development of vascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Disruption of adiponectin causes insulin resistance and neointimal formation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

21 January 2018

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity-induced inflammatory changes in adipose tissue.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2007.50

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/AJH.2007.50

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/18188158

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46813413&oldid=2133338328"